An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
NCT06799611
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenia (ITP)
Treatment
Interventions
DRUG:
CM336 Injection
Sponsor
Institute of Hematology & Blood Diseases Hospital, China